Clinical Trial Details
| Trial ID: | L0279 |
| Source ID: | NCT03963921 |
| Associated Drug: | HepaStem |
| Title: | Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH Patients |
| Acronym: | PANASH |
| Status: | Completed |
| Study Results: | No Results Available |
| Results: | -- |
| Conditions: | NASH - Nonalcoholic Steatohepatitis |
| Interventions: | Drug: HepaStem |
| Outcome Measures: | Incidence of Adverse Event |
| Sponsor/Collaborators: | Promethera Therapeutics |
| Gender: | All |
| Age: | 18 Years to 70 Years ?? (Adult, Older Adult) |
| Phases: | Phase 1/Phase 2 |
| Enrollment: | 23 |
| Study Type: | Interventional |
| Study Designs: | Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment |
| Start Date: | April 9, 2019 |
| Completion Date: | August 31, 2020 |
| Results First Posted: | -- |
| Last Update Posted: | October 14, 2020 |
| Locations: | Cliniques Universitaires St Luc, Brussels, Belgium|CUB Erasme, Brussel, Belgium|University Hospital Antwerp (UZA), Edegem, Belgium|UZ Gent, Gent, Belgium|University Multiprofile Hospital for Active Treatment "Tsaritsa Yoana - ISUL", Sofia, Bulgaria|Multiprofile hospital for active treatment (MHAT) Sofia Military Medical Academy, Sofia, Bulgaria|Trakia Park Hospital, Stara Zagora, Bulgaria|CHU Bordeaux, Bordeaux, France|Paul Brousse Hospital, Villejuif, France|Vall d'Hebron, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital General Universitario Gregorio Mara??on, Madrid, Spain|Hospital Universitario Ram??n y Cajal, Madrid, Spain |
| URL: | https://ClinicalTrials.gov/show/NCT03963921 |
